top of page

Search

Halomine accepted into IndieBio's inaugural New York accelerator program

Jun 11, 20201 min read

Read about our acceptance into one of the nation's best accelerator programs, on IndieBio's website.

Recent Posts

AvantGuard’s Mission To Combat Candida Auris and Replace Topical Antibiotics

AvantGuard is a finalist in the RESI Boston Innovator's Pitch Challenge

AvantGuard Named Semi-Finalist in 2024 Pepperdine Most Fundable Companies Competition

コメント

bottom of page